I-HoP:Drug Development in the Pharmaceutical Industry(9/4)
Transferable Skills Seminar – Drug Development in the Pharmaceutical Industry: The Career Path, Landscape and Future
This transferable skills seminar is targeted international researchers (DC, PD and MC).
Seminar will be conducted in English.
The landscape of drug development in the pharmaceutical industry changes in a short timeframe. Once the seeds show promising potential in the venture company or startup companies, these seeds will be bought by large pharmaceutical companies which have abundant resources to run clinical trials. Running clinical trials is extremely expensive and the average cost exceeds billion dollars. Therefore, any pharmaceutical companies make efforts to minimize the cost, maximize efficiencies toward early approval of the drug. Many animal studies and pharmacology studies are often outsourced to the contract research organizations (CROs) and academic institutions. Depending on the expertise, the career path crosses between the sponsor and CROs. It is important for your career planning to understand the structure and functions of the matrix team of the pharmaceutical companies and identify where your strength contributes most.
■ Seminar date
9/4 (Fri.) 9:00-10:30 Online
*Live from the USA
Tomoko Maeda-Chubachi, MD, PhD, MBA, Founder and Chief Mentor, The Institute of Drug Development Career Promotion; Vice President, Medical, Novan, Inc.
Tomoko Maeda-Chubachi, MD, PhD, MBA graduated from Osaka University, and completed MD (1991) and PhD (1996) programs. She trained in the postdoctoral fellowship programs in Boston University (1995-1997), US, and University of Alberta (2000-2002), Canada. She was a board-certified dermatologist. She entered the pharmaceutical industry in 2002, starting from Pfizer Japan as a Japan Development Team Leader, and moved to the US (2006) as a Clinical Lead in the ophthalmology and dermatology therapeutic areas. She was a Senior Medical Advisor and Senior Medical Director at Eli Lily and Company (2011) and at GSK (2014), respectively, to lead global clinical development projects for psoriasis, atopic dermatitis, pemphigus, and androgenic alopecia and negotiated the regulatory authorities (FDA, EMA, PMDA) for the approval. Since 2017, she provides medical input to help drive the strategy, design, and execution of Novan’s development programs as the Vice President in Medical. In 2019, she founded the Institute of Drug Development Career Promotion as a nonprofit organization in order to promote career development in the drug development arena for young physicians and scientists.
DC,PD and MC
▽DDCP (in Japanese)
■ Maximum number of participants
*You need to be registered on Hi-Systemv in advance.
If you are not, please go to Hi-System page in Front Office for Human Resource Education and Development homepage and register in Hi-System.
:For more details